Form D · Pharmaceuticals
PINNACLE PHARMACEUTICALS INC
Radford, VA · CIK 0001122216
Offering snapshot reported Jul 27, 2011 · SEC filing
- Reported sold
- $8.02M Offering amount: $16M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Jul 12, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 27, 2011 | Initial | $8,015,002 | No comparison | 2 | SEC filing |
| Jun 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-163545
Source: Form D, filed Jul 27, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Theodore J. Fisher | Director, Executive |
| Randal J. Kirk | Director |
| Krish S. Krishnan | Director, Executive |
| Suma M. Krishnan | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1881 Grove Avenue
Radford, VA, 24141
Radford, VA, 24141